An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination

Abstract Background Current acute myeloid leukemia (AML) therapy fails to eliminate quiescent leukemic blasts in the bone marrow, leading to about 50% of patient relapse by increasing AML burden in the bone marrow, blood, and extramedullar sites. We developed a protein-based nanoparticle conjugated...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Victor Pallarès, Ugutz Unzueta, Aïda Falgàs, Laura Sánchez-García, Naroa Serna, Alberto Gallardo, Gordon A. Morris, Lorena Alba-Castellón, Patricia Álamo, Jorge Sierra, Antonio Villaverde, Esther Vázquez, Isolda Casanova, Ramon Mangues
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-04-01
coleção:	Journal of Hematology & Oncology
Assuntos:	Acute myeloid leukemia CXCR4 Targeted nanoparticle Auristatin nanoconjugate Leukemic stem cells Disseminated AML mouse model
Acesso em linha:	http://link.springer.com/article/10.1186/s13045-020-00863-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!